SCHEMBL16812

SCHEMBL16812

O=S(=O)(C1=CC=CCC1=S)N1CCNC(CC2CCOCC2)C1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GCKR Q14397 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL17471 0.99 — —
SCHEMBL17125 0.82 — —
SCHEMBL16867 0.79 GCKR (0.33) GCKR
Hydrochloric Acid SCHEMBL23484 0.78 GCKR (0.33) GCKR
SCHEMBL12078539 0.78 CYP3A4 (0.40) —
SCHEMBL16420 0.77 CA1 (0.41) —
Hydrochloric Acid SCHEMBL16218 0.77 CYP3A4 (0.40) —
SCHEMBL12077490 0.73 CTSL (0.34) —
SCHEMBL16814 0.73 — —
SCHEMBL22891 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 — — EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 — — WO disclosed
Send feedback